Tag Archives: Prostate cancer

28Aug/24

Johnson & Johnson is transforming solid tumor cancer outcomes with new data at the 2024 World Conference on Lung Cancer and European Society for Medical Oncology Congress

August 28, 2024ReasearchCancer, Johnson & Johnson, Oncology, Prostate canceradmin

Johnson & Johnson (NYSE: JNJ) announced today that 11 oral presentations from the Company’s industry-leading solid tumor portfolio and pipeline will be featured at the 2024 World Conference on Lung Cancer (WCLC) and the European Society for Medical Oncology (ESMO) 2024 Congress. Twenty-seven studies (23 company-sponsored and four investigator-initiated), including four late-breaking abstracts, will feature new data in lung, bladder, prostate, and colorectal cancers. Continue reading

11Mar/23

New Research in JNCCN Highlights the Negative Impact of Continued Exclusion of Racial Groups from Research on Cancer Genomics

March 11, 2023ReasearchBranches of biology, Cancer, Clinical medicine, Genetic testing, Medical genetics, Medicine, National Comprehensive Cancer Network, Prostate cancer, Prostate cancer screening, RTT, War on Canceradmin

New research in the March 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network highlights how the lack of genomic research for people with African ancestry, particularly those from the Sub-Saharan region, is hampering efforts to reduce disparities for people with cancer. In a first-of-its-kind study, the researchers evaluated molecular genetic results for 113 Black South African men diagnosed with advanced prostate cancer to find evidence for increased and potentially unique genetic testing recommendations. Continue reading

03Mar/23

PROSTATE CANCER FOUNDATION-FUNDED GENETIC STUDY OF MEN OF AFRICAN ANCESTRY FINDS NEW RISK FACTORS FOR PROSTATE CANCER

March 3, 2023HealthcareActive surveillance of prostate cancer, Cancer, Clinical medicine, Health, Histopathology, Medical terminology, Medicine, Prostate, Prostate cancer, Prostate Cancer Foundation, RTT, Screening, United Statesadmin

One in six Black men in the United States will be diagnosed with prostate cancer in his lifetime versus one in eight white men. Black men are more likely to be diagnosed at a younger age, with more aggressive disease, and are more than twice as likely to die of prostate cancer. New findings from Prostate Cancer Foundation (PCF)-funded investigators shed light on the genetic underpinnings of this racial disparity and point the way toward more effective screening strategies. Continue reading

Tag: Prostate cancer